Promising COVID oral antiviral being co-researched by Healion Bio and FUJIFILM Toyama
Promising COVID oral antiviral being co-researched by Healion Bio and FUJIFILM Toyama April 28, 2022 FREDERICK, Md., April 28, 2022 /PRNewswire/ — Healion Bio, a closely held biotechnology company, today announced a collaborative agreement to research a combination antiviral against SARS-CoV-2 and other deadly pathogens. The combination will include one of Healion Bio’s protease inhibitors …
Promising COVID oral antiviral being co-researched by Healion Bio and FUJIFILM Toyama Read More »